tetano
Editor, Senior Moderator
Arch Clin Neuropsychol
. 2024 Mar 22:acae017.
doi: 10.1093/arclin/acae017. Online ahead of print. Neurocognitive Impairment in Post-COVID-19 Condition in Adults: Narrative Review of the Current Literature
William Garmoe[SUP] 1 [/SUP], Kavitha Rao[SUP] 2 [/SUP], Bethany Gorter[SUP] 3 [/SUP], Rachel Kantor[SUP] 3 [/SUP]
Affiliations
The severe acute respiratory syndrome coronavirus 2 virus has, up to the time of this article, resulted in >770 million cases of COVID-19 illness worldwide, and approximately 7 million deaths, including >1.1 million in the United States. Although defined as a respiratory virus, early in the pandemic, it became apparent that considerable numbers of people recovering from COVID-19 illness experienced persistence or new onset of multi-system health problems, including neurologic and cognitive and behavioral health concerns. Persistent multi-system health problems are defined as Post-COVID-19 Condition (PCC), Post-Acute Sequelae of COVID-19, or Long COVID. A significant number of those with PCC report cognitive problems. This paper reviews the current state of scientific knowledge on persisting cognitive symptoms in adults following COVID-19 illness. A brief history is provided of the emergence of concerns about persisting cognitive problems following COVID-19 illness and the definition of PCC. Methodologic factors that complicate clear understanding of PCC are reviewed. The review then examines research on patterns of cognitive impairment that have been found, factors that may contribute to increased risk, behavioral health variables, and interventions being used to ameliorate persisting symptoms. Finally, recommendations are made about ways neuropsychologists can improve the quality of existing research.
Keywords: COVID-19; Cognitive impairment; Long-COVID; PASC; PCC.
. 2024 Mar 22:acae017.
doi: 10.1093/arclin/acae017. Online ahead of print. Neurocognitive Impairment in Post-COVID-19 Condition in Adults: Narrative Review of the Current Literature
William Garmoe[SUP] 1 [/SUP], Kavitha Rao[SUP] 2 [/SUP], Bethany Gorter[SUP] 3 [/SUP], Rachel Kantor[SUP] 3 [/SUP]
Affiliations
- PMID: 38520374
- DOI: 10.1093/arclin/acae017
The severe acute respiratory syndrome coronavirus 2 virus has, up to the time of this article, resulted in >770 million cases of COVID-19 illness worldwide, and approximately 7 million deaths, including >1.1 million in the United States. Although defined as a respiratory virus, early in the pandemic, it became apparent that considerable numbers of people recovering from COVID-19 illness experienced persistence or new onset of multi-system health problems, including neurologic and cognitive and behavioral health concerns. Persistent multi-system health problems are defined as Post-COVID-19 Condition (PCC), Post-Acute Sequelae of COVID-19, or Long COVID. A significant number of those with PCC report cognitive problems. This paper reviews the current state of scientific knowledge on persisting cognitive symptoms in adults following COVID-19 illness. A brief history is provided of the emergence of concerns about persisting cognitive problems following COVID-19 illness and the definition of PCC. Methodologic factors that complicate clear understanding of PCC are reviewed. The review then examines research on patterns of cognitive impairment that have been found, factors that may contribute to increased risk, behavioral health variables, and interventions being used to ameliorate persisting symptoms. Finally, recommendations are made about ways neuropsychologists can improve the quality of existing research.
Keywords: COVID-19; Cognitive impairment; Long-COVID; PASC; PCC.
